Last updated: 2026-09-16 10:31:00. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
ENvue Medical, Inc. (FEED) operates in the ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES sector and is listed on NASDAQ. The stock is currently priced at $1.02, with a market capitalisation of $3.09M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.84 to $73.08. This page covers its latest market performance, valuation, price trends and company information.
$3.09M | |
$3.34 | |
$2,557.19 | |
$0.84 | |
$3.35 | |
899.69K | |
90.34K | |
-- | |
$73.08 | |
$0.84 | |
-- | |
-- |
ENvue Medical, Inc. (FEED) is trading at $3.43 in pre-market trading as of 2026-09-16 00:00:00, up 2.33% ($0.08) from the previous close of $3.35
Pre-market trading shows how investors are pricing FEED before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.
Over the past seven days, ENvue Medical, Inc. (FEED) moved from $4.03 to $1.02, representing a decline of 74.71% ($3.01).
The stock traded between $0.84 and $4.62 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 271.77 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 0.2%
FEED is currently trading at $1.02, placing it 0.2% of the way from its 52-week low of $0.84 to its 52-week high of $73.08. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
ENvue Medical Inc is a medical technology company specializing in the advancement of intelligent, non-invasive solutions for enteral care across clinical and home care settings. It focuses on two technology platforms: the ENvue Navigation Platform, which provides an electromagnetic navigation system intended to assist clinicians in placing feeding tubes into the gastrointestinal tract; FDA 510(k) cleared for adult use, it provides real-time bedside visualization of tube movement and supports informed decision-making during the placement procedure. Its Medical advances non-invasive therapy and minimally invasive navigation, with a commitment to patient safety, clinical usability, and technology innovation in healthcare environments, and the company's acoustic-based therapeutic technologies.
| Industry | ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES |
| Employees | 14 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of ENvue Medical, Inc. (FEED) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.